about
Manufacturing of AcMNPV baculovirus vectors to enable gene therapy trialsRecombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccineBaculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in MiceSubcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesIntranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virusMucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster.Baculovirus: an insect-derived vector for diverse gene transfer applicationsEnhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative studyInsect cell technology is a versatile and robust vaccine manufacturing platform.Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.The Pacific White Shrimp β-actin Promoter: Functional Properties and the Potential Application for Transduction System Using Recombinant Baculovirus.Efficient gene delivery into cell lines and stem cells using baculovirus.Development of hybrid baculovirus vectors for artificial MicroRNA delivery and prolonged gene suppression.High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.Transgene expression in Penaeus monodon cells: evaluation of recombinant baculoviral vectors with shrimp specific hybrid promotersDevelopment of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy.Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection.How can we develop universal H5N1 vaccines.Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
P2860
Q26767368-687F9598-E988-4192-A9E9-07BC39B22107Q30221529-B8311E05-F5FB-4E4A-9FC9-3223A07715DDQ30386196-D7BC1394-EE2A-476F-94A8-C0C5054E371FQ30404811-E6BB31D0-A007-489C-BC1B-FC4548B2A15CQ30427591-E999F4EF-2CEC-49AA-A7E1-E079970DD43FQ30431867-C5B406F2-0AA4-4E92-AC47-37826694D3E0Q35565185-61BD54D2-A29F-4817-9A5B-EC2FF02BE5F2Q36740261-0C02E50D-D67B-4FFB-A30C-E60B0B83E5CBQ37080370-FBEC57F6-8F4F-4649-ACEA-7038A231265CQ37909427-CA63865C-E703-4A81-8FD4-7B48FE3FBA77Q38243160-5279D025-F6EC-4B2B-A3B6-7FF3F4EA24B0Q38771061-ED75642F-D133-4809-89DB-7572F41ABE43Q38976671-F40B902C-7C8B-4041-8E27-1B4C1D2A4F26Q39512175-46446DE6-96C0-429C-AD66-8EB19D25896CQ41051865-1D26C101-CA6A-4E3D-9E6E-D88E337EA73FQ41404819-E808D1ED-39A5-4ADA-86C6-9B875838A6D9Q41732745-045856EC-4C71-4124-A3D0-F9701C055C55Q44162630-8E9CD3E5-DC7E-455E-94AF-B59FBAAA5C14Q45325594-3EAFF80E-1959-4FF1-9E80-264D77B533CBQ50948360-F2A539A7-600E-4D97-A5AF-7D370C18730CQ56514706-AE82F088-D6F7-4AFB-8B2B-C00A0EE147D5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Baculovirus as vaccine vectors.
@en
Baculovirus as vaccine vectors.
@nl
type
label
Baculovirus as vaccine vectors.
@en
Baculovirus as vaccine vectors.
@nl
prefLabel
Baculovirus as vaccine vectors.
@en
Baculovirus as vaccine vectors.
@nl
P1433
P1476
Baculovirus as vaccine vectors.
@en
P2093
Mookkan Prabakaran
Selvaraj Madhan
P304
P356
10.2174/156652310791321233
P407
P50
P577
2010-06-01T00:00:00Z